Paul Byrne MSc, PhD

Dr. Paul Byrne is a Principal Scientist at Covance, focusing on the evolving field of cell and gene therapies, providing scientific and regulatory leadership and direction on projects throughout the drug development continuum. In addition, he leads an integrated global Covance team delivering innovative analytical solutions for clients’ cell and gene therapy programs. In this role, Byrne also brings clients specialized expertise in the development and validation of analytical tools and strategies, and the development of regulatory-compliant and molecular biology.

Byrne has over 20 years of industry experience and can frequently be found speaking at symposia on topics such as analytical development challenges for ATMPs, biodistribution, safety assessment considerations for cell and gene therapies, and more. Paul received his BSc (Hons) in biology from the University of Stirling (UK) and his MSc in research from the University of Glasgow (UK).